Skip to content

Digital Continuity-of-Care Platform–Based Real-World Prospective Registry Cohort Study in Newly Diagnosed Type 2 Diabetes

Digital Continuity-of-Care Platform–Based Real-World Prospective Registry Cohort Study in Newly Diagnosed Type 2 Diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122422
Enrollment
Unknown
Registered
2026-04-14
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Newly diagnosed type 2 diabetes

Interventions

Intensive Management Cohort:None
Digital self-service cohort:None
Long-range escort cohort:None

Sponsors

Ningbo First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years and voluntarily sign the informed consent form; 2. Diabetes-related autoantibodies (e.g. GADAb) are negative, excluding type 1 diabetes, gestational diabetes, or other specific types of diabetes. 3. BMI >= 24 kg/m ² or waist circumference (male >= 85cm/female >= 80cm); 4. The ß-cell function was preserved, C-peptide >= 1.1 µg/L in fasting and 2.5 µg/L in 2h postprandial; 5. Newly diagnosed T2DM or diagnosed for less than 5 years. 6. Able to operate a smartphone and cooperate with digital follow-up and data collection.

Exclusion criteria

Exclusion criteria: 1. Life expectancy < 5 years or accompanied by severe non-diabetes-related comorbidities (such as malignant tumors, end-stage organ failure); 2. Individuals with severe mental disorders, cognitive dysfunction, or those unable to use the digital platform.

Design outcomes

Primary

MeasureTime frame
Diabetes Clinical Remission Rate;

Secondary

MeasureTime frame
Digital Behavioral Indicators;Macrovascular and microvascular Outcomes;Metabolic Improvement Indicators;All-cause Mortality;

Countries

China

Contacts

Public ContactLi Jialin

Ningbo First Hospital

lijialin@sina.com+86 574 87089140

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026